Showing results (1631-1640 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|April 1, 1997
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'AdulteC Gisselbrecht, C Haioun, E Lepage, et al.Leukemia & Lymphoma|April 1, 1997
Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemiaA Gagro, G Dasić, A Sabioncello, et al.Leukemia & Lymphoma|April 1, 1997
Intermittent infusion of cladribine (CdA) in previously treated patients with low-grade non-Hodgkin's lymphomaJ Liliemark, A Porwit, G JuliussonLeukemia & Lymphoma|April 1, 1997
Dose escalation of epirubicin in the CEOP-BLEO regimen: a controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphomaA Avilés, A Calva, J C Díaz-Maqueo, et al.Leukemia & Lymphoma|May 1, 1996
Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemiaT Mainou-Fowler, A G PrenticeLeukemia & Lymphoma|May 1, 1996
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemiaA Rambaldi, V Attuati, R Bassan, et al.Leukemia & Lymphoma|May 1, 1996
Molecular characterization of an unusual non-Hodgkin's B-lymphoma cell line ("Farage") lacking the ability to produce immunoglobulin polypeptide chainsM Baruch, M Hochberg, C Gabay, et al.Leukemia & Lymphoma|May 1, 1996
A patient with Werner's syndrome and erythroleukemia: just coincidence?C Bartal, R Yerushalmi, D Zilberman, et al.Leukemia & Lymphoma|October 1, 1993
Detection of minimal residual disease in Philadelphia chromosome positive acute lymphoblastic leukemia: rationale for bone marrow transplantation from the polymerase chain reaction point of viewK Miyamura, T Takeo, T Kataoka, et al.Leukemia & Lymphoma|October 1, 1993
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adultsA Avilés, N Arévila, J C Díaz Maqueo, et al.Pageof 998